Nucleus
Signal active
Organization
Contact Information
Overview
Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
About
Industries
Biotechnology, Health Care
Founded
2021
Employees
1-10
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Nucleus headquartered in New York, New York, United States, North America, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $280.0M in funding across 16 round(s). With a team of 1-10 employees, Nucleus is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Nucleus, raised $14.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
10
Lead Investors
0
Total Funding Amount
$17.5M
Details
2
Nucleus has raised a total of $17.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 3.5M | ||
| 2022 | Seed | 14.0M |
Investors
Nucleus is funded by 35 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Nucleus | - | FUNDING ROUND - Nucleus | 14.0M |
| Seven Seven Six | - | FUNDING ROUND - Seven Seven Six | 14.0M |
| Nucleus | - | FUNDING ROUND - Nucleus | 14.0M |
| Nicholas Donahue | - | FUNDING ROUND - Nicholas Donahue | 14.0M |
Recent Activity
There is no recent news or activity for this profile.